The Journal of Organic Chemistry
Article
7.2 Hz, 3H). 13C{1H} NMR (101 MHz, CDCl3): δ 157.8, 146.8,
138.6, 128.5, 128.3, 127.5, 125.9, 113.1, 55.2, 43.9, 22.1.
mg, 0.25 mmol) and phenylboronic acid 2g (61.0 mg, 0.5 mmol). 3eg
was isolated in high purity without further purification as a colorless
oil in 87% yield (46.2 mg, 0.22 mmol). The enantiomeric excess was
determined by HPLC analysis (220 nm, 25 °C) tR 17.6 min (major);
tR 19.0 min (minor) [CHIRALCEL OJ-H (0.46 cm × 25 cm) (from
Daicel Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 1.0 mL/min] to be
87% ee. [α]2D4 = +1.55° (c 0.58, CHCl3). 1H NMR (400 MHz,
CDCl3): δ 7.31−7.28 (m, 2H), 7.25−7.15 (m, 5H), 6.85 (d, J = 8.7
Hz, 2H), 4.13 (d, J = 7.2 Hz, 1H), 3.80 (s, 3H), 1.64 (d, J = 7.2 Hz,
3H). 13C{1H} NMR (101 MHz, CDCl3): δ 157.8, 146.8, 138.6, 128.5,
128.3, 127.5, 125.9, 113.1, 55.2, 43.9, 22.1.
4.4.2. (R)-1-Methyl-4-(1-phenylethyl)benzene (3ab).3d Prepared
according to the general procedure from styrene 1a (26.0 mg, 0.25
mmol) and 4-methylphenylboronic acid 2b (68.0 mg, 0.5 mmol). 3ab
was isolated in high purity without further purification as a colorless
oil in 93% yield (49.3 mg, 0.23 mmol). The enantiomeric excess was
determined by HPLC analysis (220 nm, 25 °C) tR 11.5 min (minor);
tR 12.6 min (major) [CHIRALCEL OJ-H (0.46 cm × 25 cm) (from
Daicel Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 1.0 mL/min] to be
88% ee. [α]2D4 = −1.60° (c 0.6, CHCl3). 1H NMR (400 MHz,
CHCl3): δ 7.34−7.30 (m, 2H), 7.28−7.26 (m, 2H), 7.24−7.19 (m,
1H), 7.18−7.13 (m, 4H), 4.17 (q, J = 7.2 Hz, 1H), 2.36 (s, 3H), 1.67
(d, J = 7.2 Hz, 3H). 13C{1H} NMR (101 MHz, CDCl3): δ 146.6,
143.4, 135.5, 129.1, 128.4, 127.6, 127.5, 126.0, 44.4, 22.0, 21.0.
4.4.3. (R)-1-Fluoro-4-(1-phenylethyl)benzene (3ac).3e Prepared
according to the general procedure from styrene 1a (26.0 mg, 0.25
mmol) and 4-fluorophenylboronic acid 2c (70.0 mg, 0.5 mmol). 3ac
was isolated in high purity without further purification as a colorless
oil in 93% yield (46.6 mg, 0.23 mmol). The enantiomeric excess was
determined by HPLC analysis (220 nm, 25 °C) tR 8.7 min (minor); tR
10.3 min (major) [CHIRALCEL OJ-H (0.46 cm × 25 cm) (from
Daicel Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 1.0 mL/min] to be
72% ee. [α]2D4 = −1.30° (c 0.74, CHCl3). 1H NMR (400 MHz,
CDCl3): δ 7.32−7.28 (m, 2H), 7.22−7.16 (m, 5H), 6.98 (t, J = 8.7
Hz, 2H), 4.15 (q, J = 7.2 Hz, 1H), 1.64 (d, J = 7.2 Hz, 3H). 13C{1H}
4.4.8. (S)-1-Methoxy-4-(1-(4-(trifluoromethyl)phenyl)ethyl)-
benzene (3eh).2c Prepared according to the general procedure from
4-methoxystyrene 1e (33.5 mg, 0.25 mmol) and 4-(trifluoromethyl)-
phenylboronic acid 2h (95.0 mg, 0.5 mmol). 3eh was isolated in high
purity without further purification as a colorless oil in 85% yield (59.6
mg, 0.21 mmol). The enantiomeric excess was determined by HPLC
analysis (220 nm, 25 °C) tR 7.0 min (major); tR 9.7 min (minor)
[CHIRALCEL OJ-H (0.46 cm × 25 cm) (from Daicel Chemical Ind.,
Ltd.) hexane/iPrOH, 90:10, 1.0 mL/min] to be 79% ee. [α]D24
=
+1.74° (c 0.54, CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.55 (d, J =
8.1 Hz, 2H), 7.33 (d, J = 8.1 Hz, 2H), 7.15 (d, J = 8.4 Hz, 2H), 6.87
(d, J = 8.7 Hz, 2H), 4.18 (d, J = 7.2 Hz, 1H), 3.80 (s, 3H), 1.65 (d, J =
7.3 Hz, 3H). 13C{1H} NMR (101 MHz, CDCl3): δ 158.1, 150.9,
137.4, 128.5, 128.3 (d, C−F, 2JC−F = 32.3 Hz), 127.9, 125.3 (q, C−F,
3JC−F = 3.8 Hz), 124.3 (d, C−F, 1JC−F = 272.7 Hz), 113.9, 55.2, 43.9,
21.8. 19F NMR (376 MHz, CDCl3): δ −62.3.
1
NMR (101 MHz, CDCl3): δ 161.3 (d, C−F, JC−F = 243.9 Hz),
4
3
4.4.9. (R)-1-Methoxyl-3-(1-phenylethyl)benzene (3ai).31 Prepared
according to the general procedure from styrene 1a (26.0 mg, 0.25
mmol) and 3-methoxyphenylboronic acid 2i (76.0 mg, 0.5 mmol). 3ai
was isolated in high purity without further purification as a colorless
oil in 82% yield (43.5 mg, 0.20 mmol). The enantiomeric excess was
determined by HPLC analysis (220 nm, 25 °C) tR 7.2 min (minor); tR
7.7 min (major) [CHIRALCEL OD-H (0.46 cm × 25 cm) (from
Daicel Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 1.0 mL/min] to be
77% ee. [α]2D4 = −1.21° (c 0.76, CHCl3). 1H NMR (400 MHz,
CDCl3): δ 7.33−7.30 (m, 2H), 7.27−7.19 (m, 4H), 6.86 (d, J = 8.0
Hz, 1H), 6.82 (t, J = 2.4 Hz, 1H), 6.76 (dd, J = 8.2, 2.6 Hz, 1H), 4.16
(q, J = 7.2 Hz, 1H), 3.80 (s, 3H), 1.67 (d, J = 7.2 Hz, 3H). 13C{1H}
NMR (101 MHz, CDCl3): δ 159.6, 148.1, 146.2, 129.3, 128.4, 127.6,
126.1, 120.1, 113.8, 111.0, 55.1, 44.8, 21.8.
146.2, 142.0 (d, C−F, JC−F = 3.4 Hz), 129.0 (d, C−F, JC−F = 7.7
Hz), 128.4, 127.5, 126.2, 115.1 (d, C−F, 2JC−F = 21.1 Hz), 44.0, 22.0.
19F NMR (376 MHz, CDCl3): δ −117.5.
4.4.4. (R)-1-Chloro-4-(1-phenylethyl)benzene (3ad).3d Prepared
according to the general procedure from styrene 1a (26.0 mg, 0.25
mmol) and 4-chlorophenylboronic acid 2d (78.2 mg, 0.5 mmol). 3ad
was isolated in high purity without further purification as a colorless
oil in 57% yield (30.9 mg, 0.14 mmol). The enantiomeric excess was
determined by HPLC analysis (220 nm, 25 °C) tR 7.7 min (minor); tR
8.4 min (major) [CHIRALCEL OJ-H (0.46 cm × 25 cm) (from
Daicel Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 1.0 mL/min] to be
77% ee. [α]2D4 = −1.5° (c 0.64, CHCl3). 1H NMR (400 MHz,
CDCl3): δ 7.33−7.16 (m, 9H), 4.15 (q, J = 7.2 Hz, 1H), 1.64 (d, J =
7.2 Hz, 3H). 13C{1H} NMR (101 MHz, CDCl3): δ 145.8, 144.9,
131.8, 129.0, 128.5, 128.5, 127.5, 126.3, 44.2, 21.8.
4.4.10. (R)-3-(1-Phenylethyl)phenol (3aj).9a Prepared according to
the general procedure from styrene 1a (26.0 mg, 0.25 mmol) and 3-
hydroxyphenylboronic acid 2j (69.0 mg, 0.5 mmol). 3aj was isolated
in high purity without further purification as a colorless oil in 85%
yield (42.1 mg, 0.21 mmol). The enantiomeric excess was determined
by HPLC analysis (220 nm, 25 °C) tR 28.4 min (major); tR 38.4 min
(minor) [CHIRALCEL OJ-H (0.46 cm × 25 cm) (from Daicel
Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 1.0 mL/min] to be 86%
ee. [α]2D4 = −1.11° (c 0.54, CHCl3). 1H NMR (400 MHz, CDCl3): δ
7.36−7.29 (m, 2H), 7.26−7.15 (m, 4H), 6.84 (d, J = 7.6 Hz, 1H),
6.69−6.65 (m, 2H), 4.79 (s, 1H), 4.12 (q, J = 7.2 Hz, 1H), 1.64 (d, J
= 7.2 Hz, 3H). 13C{1H} NMR (101 MHz, CDCl3): δ 155.4, 148.4,
146.1, 129.6, 128.4, 127.6, 126.1, 120.2, 114.6, 113.0, 44.6, 21.7.
4.4.11. (R)-1-Methoxy-2-(1-phenylethyl)benzene (3ak).32 Pre-
pared according to the general procedure from styrene 1a (26.0
mg, 0.25 mmol) and 2-methoxyphenylboronic acid 2g (76.0 mg, 0.5
mmol). 3ak was isolated in high purity without further purification as
a colorless oil in 83% yield (44.1 mg, 0.21 mmol). The enantiomeric
excess was determined by HPLC analysis (220 nm, 25 °C) tR 9.0 min
(major); tR 14.1 min (minor) [CHIRALCEL OJ-H (0.46 cm × 25
cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 1.0
4.4.5. Methyl (R)-4-(1-Phenylethyl)benzoate (3ae).6c Prepared
according to the general procedure from styrene 1a (26.0 mg, 0.25
mmol) and 4-(methoxycarbonyl)phenyl)boronic acid 2e (90.0 mg,
0.5 mmol). 3ae was isolated in high purity without further purification
as a colorless oil in 86% yield (52.9 mg, 0.22 mmol). The
enantiomeric excess was determined by HPLC analysis (220 nm, 25
°C) tR 6.0 min (major); tR 6.8 min (minor) [CHIRALCEL AS-H
(0.46 cm × 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH,
90:10, 1.0 mL/min] to be 74% ee. [α]2D4 = −0.82° (c 0.78, CHCl3).
1H NMR (400 MHz, CDCl3): δ 7.98 (d, J = 8.3 Hz, 2H), 7.33−7.29
(m, 4H), 7.23−7.20 (m, 3H), 4.22 (q, J = 7.2 Hz, 1H), 3.91 (s, 3H),
1.67 (d, J = 7.2 Hz, 3H). 13C{1H} NMR (101 MHz, CDCl3): δ 167.0,
151.7, 145.4, 129.8, 128.5, 128.0, 127.7, 127.6, 126.3, 52.0, 44.8, 21.6.
4.4.6. (R)-1-(4-(1-Phenylethyl)phenyl)ethan-1-one (3af).30 Pre-
pared according to the general procedure from styrene 1a (26.0 mg,
0.25 mmol) and 4-acetylphenylboronic acid 2f (82.0 mg, 0.5 mmol).
3af was isolated in high purity without further purification as a
colorless oil in 82% yield (45.9 mg, 0.20 mmol). The enantiomeric
excess was determined by HPLC analysis (220 nm, 25 °C) tR 10.9
min (minor); tR 11.4 min (major) [CHIRALCEL AS-H (0.46 cm ×
25 cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 98:2, 1.0
mL/min] to be 92% ee. [α]2D4 = −1.45° (c 0.62, CHCl3). H NMR
1
mL/min] to be 74% ee. [α]2D4 = −1.1° (c 0.86, CHCl3). H NMR
(400 MHz, CDCl3): δ 7.35−7.30 (m, 4H), 7.26−7.19 (m, 3H), 6.97
(td, J = 7.5, 1.2 Hz, 1H), 6.90 (dd, J = 8.1 Hz, 1.2 Hz, 1H), 4.65 (q, J
= 7.3 Hz, 1H), 3.82 (s, 3H), 1.65 (d, J = 7.3 Hz, 3H). 13C{1H} NMR
(101 MHz, CDCl3): δ 156.9, 146.4, 134.9, 128.1, 127.8, 127.7, 127.1,
125.7, 120.6, 110.6, 55.4, 37.4, 21.0.
1
(400 MHz, CDCl3): δ 7.89 (d, J = 8.4 Hz, 2H), 7.34−7.29 (m, 4H),
7.23−7.19 (m, 3H), 4.22 (q, J = 7.2 Hz, 1H), 2.58 (s, 3H), 1.67 (d, J
= 7.2 Hz, 3H). 13C{1H} NMR (101 MHz, CDCl3): δ 197.8, 152.0,
145.3, 135.2, 128.6, 128.5, 127.8, 127.6, 126.4, 44.8, 26.6, 21.6.
4.4.7. (S)-1-Methoxy-4-(1-phenylethyl)benzene (3eg).6a Prepared
according to the general procedure from 4-methoxystyrene 1e (33.5
4.4.12. (R)-1-Methyl-2-(1-phenylethyl)benzene (3al).32 Prepared
according to the general procedure from styrene 1a (26.0 mg, 0.25
3843
J. Org. Chem. 2021, 86, 3836−3849